Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction

Am J Cardiol. 2001 Jun 15;87(12):1408-11. doi: 10.1016/s0002-9149(01)01565-x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary
  • Blood Coagulation Factors / metabolism*
  • Double-Blind Method
  • Enalapril / adverse effects
  • Enalapril / therapeutic use*
  • Female
  • Fibrinolysis / drug effects*
  • Humans
  • Losartan / adverse effects
  • Losartan / therapeutic use*
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / drug therapy*
  • Plasminogen Inactivators / blood
  • Thrombolytic Therapy
  • Thromboplastin / metabolism
  • Tissue Plasminogen Activator / blood

Substances

  • Blood Coagulation Factors
  • Plasminogen Inactivators
  • Enalapril
  • Thromboplastin
  • Tissue Plasminogen Activator
  • Losartan